CHI’s Drug Discovery & Development Collaboration 2004

Venue: Philadelphia

Location: Philadelphia, Pennsylvania, United States

Event Date/Time: Sep 20, 2004 End Date/Time: Sep 21, 2004
Report as Spam


 Engaging Drug Discovery Science with Drug Development Early on in the Process
 Adding Business Minds to the Drug Discovery Process
 Assessing Technical Risk For Development Projects
 Using Benchmarks As Lower Limits For Attrition Rates For First-In-Class Compounds
 Creating a Corporate Culture that Enables Early Attrition
 Identify Cross-Project Dependencies, and Quantifying the Conditional Probabilities of a Drug Candidate
 Creating New Stagegate Criteria to Enter into Proof of Concept
 Making Better Decisions by Managing Resources Against Your Portfolio: An Evaluation of People, Information and Criteria that Must Be in Place
 Provide an Early Mechanism For Aligning Biomarkers And Predictability Between Discovery And Development
 Integrating Biomarkers in Early Clinical Development to Establish Preclinical Toxicology Safety
 Developing Biomarkers in Early Discovery to Better Bridge to Development
 Biomarker Analysis as a Decision Making Tool in Drug Discovery and Development